drugset
Drugs / Cligosiban
last change Aug 2019 re-read 3 minutes ago

Cligosiban

also known as CHEMBL594828 · PF 3274167

Small molecule

Developed for
premature ejaculation
Investigated by
Carelon Research · ICON plc · Ixchelsis Limited · Novotech (Australia) Pty Limited · PHT Corporation

Trials 1

today NCT02232425 · Ph 2
2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02232425 Sep 2014 → Oct 2015 premature ejaculation Ixchelsis Limited Completed Met primary

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Cligosiban “Cligosiban is an orally administered oxytocin receptor antagonist being developed to treat premature ejaculation (PE).” PMID 31351659 ↗ Aug 2019
Known as CHEMBL594828 ChEMBL registry synonym — accepted as the source's own label CHEMBL594828 ↗
Known as PF 3274167 ChEMBL registry synonym — accepted as the source's own label CHEMBL594828 ↗
Action Inhibit “Cligosiban is an orally administered oxytocin receptor antagonist” PMID 31351659 ↗ Aug 2019
Modality Small molecule — CHEMBL594828 ↗
Route Oral “Cligosiban is an orally administered oxytocin receptor antagonist” PMID 31351659 ↗ Aug 2019